Table of Contents

company-logo

Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyotrophic lateral sclerosis; VY-HTT01 for Huntington's disease; VY-FXN01 for Friedreich's ataxia; and Tau program for the treatment of tauopathies, including Alzheimer's disease, progressive supranuclear palsy, and frontotemporal dementia, as well as for spinal muscular atrophy. The company has collaboration and license agreements with Neurocrine Biosciences, Inc., Pfizer Inc., and Novartis Pharma, A.G. for the research, development, and commercialization of adeno-associated virus gene therapy products. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Cambridge, Massachusetts.

Voyager Therapeutics Dividend Announcement

• Voyager Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Voyager Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Voyager Therapeutics Dividend History

Voyager Therapeutics Dividend Yield

Voyager Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Voyager Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Voyager Therapeutics Financial Ratios

P/E ratio14.24
PEG ratio-1.28
P/B ratio1.12
ROE8.33%
Payout ratio0.00%
Current ratio8.45
Quick ratio8.45
Cash Ratio2.55

Voyager Therapeutics Dividend FAQ

Does Voyager Therapeutics stock pay dividends?
Voyager Therapeutics does not currently pay dividends to its shareholders.
Has Voyager Therapeutics ever paid a dividend?
No, Voyager Therapeutics has no a history of paying dividends to its shareholders. Voyager Therapeutics is not known for its dividend payments.
Why doesn't Voyager Therapeutics pay dividends?
There are several potential reasons why Voyager Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Voyager Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Voyager Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Voyager Therapeutics a dividend aristocrat?
Voyager Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Voyager Therapeutics a dividend king?
Voyager Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Voyager Therapeutics a dividend stock?
No, Voyager Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Voyager Therapeutics stocks?
To buy Voyager Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Voyager Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.